LFA Hematological Markers
Arista Biologicals offers hemoglobin and hemoglobin A1c antibodies specifically validated for lateral flow assay applications. Tailored for IVD manufacturers and rapid test developers, they ensure superior sensitivity, specificity, and reliability in detecting these vital hematology markers for point-of-care applications.
Routinely used in rapid tests to assess anemia status and long-term glycemic control, hemoglobin and hemoglobin A1 are critical targets for rapid, point-of-care testing.
Common Challenges Lateral Flow
Assay Developers Often Struggle With
Lot-to-lot consistency of critical reagents.
Sensitivity and linearity across ranges
Specificity avoiding hemoglobin variant interference
Stable signal at low/high physiological levels
Whether developing point-of-care diagnostics or expanding a rapid test portfolio, Arista’s antibodies provide the consistency and sensitivity required for successful lateral flow assay development.
×
